Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue

In most clinical trials, thiazolidinediones do not show any relevant anti-cancer activity when used as mono-therapy. Clinical inefficacy contrasts ambiguous pre-clinical data either favoring anti-tumor activity or tumor promotion. However, if thiazolidinediones are combined with additional regulator...

Descripción completa

Detalles Bibliográficos
Autores principales: Heudobler, Daniel, Rechenmacher, Michael, Lüke, Florian, Vogelhuber, Martin, Pukrop, Tobias, Herr, Wolfgang, Ghibelli, Lina, Gerner, Christopher, Reichle, Albrecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274845/
https://www.ncbi.nlm.nih.gov/pubmed/30424016
http://dx.doi.org/10.3390/ijms19113540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274845/
https://www.ncbi.nlm.nih.gov/pubmed/30424016
http://dx.doi.org/10.3390/ijms19113540

Ejemplares similares